รายงานการพัฒนาล่าสุดในด้านโรคภูมิแพ้และภูมิคุ้มกันวิทยาทางคลินิกที่ EAACI Congress 2024 ในเมืองบาเลนเซีย ประเทศสเปน
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 บาเลนเซีย, สเปน, March 19, 2024 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology...
Meliputi Perkembangan Terkini Alergi dan Imunologi Klinikal di Kongres EAACI 2024 di Valencia, Sepanyol
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Sepanyol, March 19, 2024 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinikal Eropah...
アレルギーと臨床免疫学の最新動向を、スペイン、バレンシアで開催される「EAACI Congress 2024」で網羅
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 スペイン、バレンシア発, March 19, 2024 (GLOBE NEWSWIRE) --...
Mengupas Kemajuan Terbaru dalam Alergi dan Imunologi Klinis pada Kongres EAACI 2024 di Valencia, Spanyol
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spanyol, March 19, 2024 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (EAACI)...
Couvrez les derniers développements en matière d'allergie et d'immunologie clinique lors du Congrès 2024 de l'EAACI à Valence en Espagne
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCE, Espagne, 19 mars 2024 (GLOBE NEWSWIRE) -- L'European Academy of Allergy and Clinical Immunology...
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical...
Sema4 to Participate at Two Investor Conferences in June 2022
May 26, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2022 16:05 ET
|
Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
May 02, 2022 07:45 ET
|
Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...
Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
April 26, 2022 16:05 ET
|
Sema4
STAMFORD, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for...